In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Catherine Longworth

Catherine Longworth is a reporter covering commercial and R&D developments in the medtech industry. A graduate of St. George's, University of London, Catherine holds a BSc in Biomedical Science. Before joining Informa, she worked in the editorial team at Pharmaceutical Press, the publishing division of the Royal Pharmaceutical Society, where she wrote and edited for a number of pharmaceutical publications. After gaining experience in the world of scientific publishing, Catherine took the leap to study a postgraduate qualification in journalism. During the course, she carried out placements with local London newspapers, writing general news and building her portfolio by reporting on a wide range of current affairs such as the European migrant crisis, political protests and the London mayoral election. Catherine is passionate about human rights and is fascinated by the innovative nature of the medtech industry and the healthcare advances that have the greatest benefit to mankind. She lives in London and loves music, arts, travel, writing, reading and is always happy to receive recommendations for books or places to travel!

Set Alert for Articles By Catherine Longworth

Latest From Catherine Longworth

Device Week, 29 November 2019 – Top Clinical Trial News From AHA & Investment Forecast From Jefferies 2019

In this week's Medtech Insight podcast, deputy editor Reed Miller discusses clinical trial news from the annual American Heart Association (AHA) meeting, and senior reporter Catherine Longworth highlights goings-on at the Jefferies Healthcare Conference in London.

Device Week Clinical Trials

Orexo Expands Digital Therapy Focus With New Platform For AUD

In an example of how so called "digital therapies" can augment traditional drug treatments, Swedish pharma company Orexo has secured exclusive US rights to an AI-based behavioral therapy for the treatment of alcohol use disorder (AUD).

Artificial Intelligence Digital Health

The 'German Robot': Avatera Throws Its Hat In Surgical Robotics Ring

German company Avatera Medical is preparing to take on the surgical robotics market with a new, CE-marked system. The company has announced a strategic plan to build a major production facility for medical robotics in Germany in 2020.

Robotic Surgery Robotics

Jefferies 2019: Investment Panel Discusses Lessons Learned

Experts shared three valuable lessons for investors to consider in their commercial strategies during a panel discussion at the recent Jefferies Healthcare Conference in London.

Jefferies 2019: Flight To Health Care Will Continue, Say Private Equity Experts

An expert panel of investors at Jefferies Healthcare Conference in London discussed the landscape for private equity investment in health-care businesses.

M & A Deals

Terumo Buys Vascular Therapy Biz Aortica

Terumo is acquiring the vascular therapy company to boost its AAA graft business.

M & A Deals
See All
UsernamePublicRestriction

Register